Deutsche Bank’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-879
Closed -$60K 4462
2022
Q1
$60K Sell
879
-421
-32% -$35K ﹤0.01% 3780
2021
Q4
$158K Sell
1,300
-548
-30% -$92.5K ﹤0.01% 3493
2021
Q3
$260K Buy
1,848
+832
+82% +$165K ﹤0.01% 3426
2021
Q2
$280K Buy
1,016
+176
+21% +$44.4K ﹤0.01% 3589
2021
Q1
$180K Buy
840
+24
+3% +$6.63K ﹤0.01% 3693
2020
Q4
$198K Buy
816
+250
+44% +$30.9K ﹤0.01% 3473
2020
Q3
$60K Buy
566
+179
+46% +$16.3K ﹤0.01% 3793
2020
Q2
$38K Buy
387
+161
+71% +$14.1K ﹤0.01% 3931
2020
Q1
$16K Sell
226
-132
-37% -$12.6K ﹤0.01% 3973
2019
Q4
$28K Buy
358
+172
+92% +$19.2K ﹤0.01% 4199
2019
Q3
$21K Sell
186
-391
-68% -$53.8K ﹤0.01% 4310
2019
Q2
$102K Sell
577
-340
-37% -$55K ﹤0.01% 4201
2019
Q1
$145K Buy
917
+15
+2% +$2.97K ﹤0.01% 4171
2018
Q4
$234K Buy
902
+294
+48% +$59.2K ﹤0.01% 3794
2018
Q3
$148K Buy
608
+94
+18% +$24.6K ﹤0.01% 4356
2018
Q2
$121K Buy
+514
New +$150K ﹤0.01% 4477

Other funds holding EVLO